The Japanese Journal of Dermatology
Online ISSN : 1346-8146
Print ISSN : 0021-499X
ISSN-L : 0021-499X
Search
Advanced search
OR
Browse
Search
Volume 122, Issue 7
Displaying 1-7 of 7 articles from this issue
Show all abstracts
    • |<
    • <
    • 1
    • >
    • >|
Guidelines
Seminar for Medical Education
Original Articles
  • Prognosis and Treatment of 383 Patients with Alopecia Areata in Our Institution
    Hideki Maejima, Norimitsu Saito, Yasuyuki Amoh, Shiro Niiyama, Akira M ...
    Article type: Original Articles
    2012 Volume 122 Issue 7 Pages 1757-1763
    Published: June 20, 2012
    Released on J-STAGE: November 13, 2014
    DOIhttps://doi.org/10.14924/dermatol.122.1757
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    The present study aimed to determine appropriate treatment for alopecia areata. We examined the clinical forms of alopecia areata and atopic diathesis and compared the content and results of treatment between 383 patients with hair loss (n=236) and atopic diathesis (n=142) at the time of the first presentation. The types of hair loss were mono, 34; oligo, 60; poly, 146; diffuse, 52; totalis, 15; universalis, 61; and ophasis, 12. Topical squaric acid dibutylester was administered to 138 patients; 126 received local injections of triamcinolone acetonide; and 126 were treated with cryotherapy. The convalescence rate was 23% among all 383 patients, 44% in those who had the mono pattern, and 20% in the others. Oral steroid combined with psoralen plus UVA irradiation was considered for patients with hair loss at the first presentation. The oral steroid was very effective, but the rate of recurrence was high among patients with atopic diathesis. We concluded that oral steroid is not indicated for patients with alopecia areata and atopic diathesis.
    View full abstract
    Download PDF (284K)
  • A Case of Cutaneous Cryptococcosis
    Tomomi Miyake, Masao Fukuzawa, Kiyoshiro Nagamatsu, Yusaku Shimizu, Ry ...
    Article type: Original Articles
    2012 Volume 122 Issue 7 Pages 1765-1772
    Published: June 20, 2012
    Released on J-STAGE: November 13, 2014
    DOIhttps://doi.org/10.14924/dermatol.122.1765
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    We report an 82-year old Japanese woman with cutaneous cryptococcosis. She had a history of rheumatoid arthritis with administration of methotrexate and infliximab. Ulcerations of her tongue and face appeared from July 2009, and she was hospitalized by complaints of both fever and loss of appetite from March 2010. Histological examinations and fungal cultures of ulcerations of tongue and face revealed cryptococcosis. On the basis of the presence of Cryptococcus neoformans in her cerebrospinal fluid, the final diagnosis was cryptococcal meningitis. We administered amphotericin B and flucytosine. the ulcerations of tongue and face achieved complete remission, but these antifungal drugs were insufficient for eliminating the meningitis, so we changed her medication and prescribed voriconazole. With this treatment, the data from cerebrospinal fluid examinations improved.
    View full abstract
    Download PDF (1448K)
Quick Reports
  • Multiple Squamous Cell Carcinoma of the Skin Caused by Sorafenib: Report of a Case
    Sumiko Takatsuka, Tatsuya Takenouchi, Yasuo Kitamura
    Article type: Quick Reports
    2012 Volume 122 Issue 7 Pages 1773-1776
    Published: June 20, 2012
    Released on J-STAGE: November 13, 2014
    DOIhttps://doi.org/10.14924/dermatol.122.1773
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    A 77-year-old man with metastatic renal cell carcinoma was treated with sorafenib (Nexavar®). After 2 months of this therapy, he developed multiple pruritic dome-shaped nodules with light-brownish or lightpinkish color on both forearms. Skin biopsies from 4 lesions revealed keratoacanthoma-type squamous cell carcinomas. The eruption has resolved after cessation of the sorafenib. In recent years, the development of keratoacanthoma and squamous cell carcinoma during sorafenib administration has been reported from other countries. It seems an important adverse event that dermatologists should recognize.
    View full abstract
    Download PDF (683K)
Abstracts
    • |<
    • <
    • 1
    • >
    • >|
feedback
 Top